Samsara Biocapital, LLC provides investment advisory services.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 14, 2022
Alpha9 Theranostics
|
Series B | $75M | Biotechnology | — |
Oct 14, 2021
Tentarix Biotherapeutics
|
Series A | $50M | Biotechnology | Yes |
Oct 7, 2021
Science 37
|
Post-IPO Equity | $200M | Biotechnology | — |
Jul 13, 2021
Prime Medicine
|
Series B | $200M | Biotechnology | — |
Oct 6, 2020
A2 Biotherapeutics
|
Series B | $71.50M | Biotechnology | — |